Ars Technica
"Truly evil" FDA rejection of gene therapy overturned after Trump official ousted
A gene therapy for Huntington's disease has a new path toward approval from the Food and Drug Administration after the ouster of several Trump officials, particularly Vinay Prasad , who rejected the therapy in a shocking move one former…
View original source — Ars Technica ↗
Related stories
CNBC
HealthJun 17, 2026 · 1 min
UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency
CNBC
Bloomberg
ScienceJun 17, 2026 · 1 min
UniQure Shares Soar After FDA Reversal on Its Huntington’s Therapy
Bloomberg
CBC
ScienceJun 5, 2026 · 1 min
Scientist with Huntington's gene dedicates life to curing fatal disease he'll one day develop
CBC
The New York Times
ScienceJun 5, 2026 · 1 min
In a First, Scientists Precisely Edit Human Embryo Genes
The New York Times